Kartagener Syndrome

An autosomal recessive disorder characterized by a triad of DEXTROCARDIA; INFERTILITY; and SINUSITIS. The syndrome is caused by mutations of DYNEIN genes encoding motility proteins which are components of sperm tails, and CILIA in the respiratory and the reproductive tracts.

Also Known As:

Kartagener's Syndrome; Syndrome, Kartagener; Syndrome, Kartagener's; Ciliary Dyskinesia, Primary, 1; Ciliary Dyskinesia, Primary, 1, With Or Without Situs Inversus; Dextrocardia, Bronchiectasis, and Sinusitis; Kartagener's Triad; Polynesian Bronchiectasis; Siewert Syndrome; Bronchiectasis, Polynesian; Kartageners Syndrome; Kartageners Triad; Polynesian Bronchiectases; Syndrome, Siewert; Kartagener Triad

Respiratory Tract Diseases: 6015
- Ciliary Motility Disorders: 433
  - Kartagener Syndrome: 129
- Bronchial Diseases: 169
  - Bronchiectasis: 3175
    - Kartagener Syndrome: 129
- Respiratory System Abnormalities
  - Kartagener Syndrome: 129
Otorhinolaryngologic Diseases: 203
- Ciliary Motility Disorders: 433
  - Kartagener Syndrome: 129
Cardiovascular Diseases: 91362
- Heart Diseases: 26014
  - Congenital Heart Defects: 8917
    - Dextrocardia: 289
      - Kartagener Syndrome: 129
- Cardiovascular Abnormalities: 452
  - Congenital Heart Defects: 8917
    - Dextrocardia: 289
      - Kartagener Syndrome: 129
Congenital, Hereditary, and Neonatal Diseases and Abnormalities: 933
- Congenital Abnormalities: 25723
  - Situs Inversus: 701
    - Dextrocardia: 289
      - Kartagener Syndrome: 129
  - Cardiovascular Abnormalities: 452
    - Congenital Heart Defects: 8917
      - Dextrocardia: 289
        Kartagener Syndrome: 129
  - Multiple Abnormalities: 211
    - Ciliopathies: 604
      - Ciliary Motility Disorders: 433
        Kartagener Syndrome: 129
  - Respiratory System Abnormalities
    - Kartagener Syndrome: 129
- Inborn Genetic Diseases: 11939
  - Ciliopathies: 604
    - Ciliary Motility Disorders: 433
      - Kartagener Syndrome: 129
  - Kartagener Syndrome: 129

João R Dias Selected Research

João R Dias Research Topics

Disease

Drug/Important Bio-Agent (IBA)